首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of cardiovascular pharmacology

缩写:J CARDIOVASC PHARM

ISSN:0160-2446

e-ISSN:1533-4023

IF/分区:2.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引2816
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Juan Antonio Requena-Ibáñez,Mohammad Urooj Zafar,Marcos Ferrandez-Escarabajal et al. Juan Antonio Requena-Ibáñez et al.
While selective SGLT2 inhibitors improve heart failure (HF) outcomes, they do not consistently reduce atherothrombotic events (myocardial infarctions and strokes). Clinical trials with sotagliflozin, the first dual SGLT1/2 inhibitor, have s...
Danny L Rayes,Hira Latif,Syed Waqas Haider Danny L Rayes
Malignant pericardial effusion, a complication of advanced malignancy, carries a poor prognosis and may be life-threatening in cases of cardiac tamponade. Treatment is challenging due to high recurrence rates. Management options include sur...
Anderson Matheus Pereira da Silva,Elaine da Silva Torres,Maria da Vitória Santos do Nascimento et al. Anderson Matheus Pereira da Silva et al.
Arterial hypertension (AH) affects over 1.28 billion adults globally, remaining a leading cause of cardiovascular morbidity and mortality. Despite effective therapies, suboptimal blood pressure control persists, highlighting the need for pr...
Nur Banu Bal,Gökhan Sadi,Aykut Bostanci et al. Nur Banu Bal et al.
Hypertension remains the leading cause of morbidity and mortality worldwide and requires more understanding of its molecular basis. This study investigated cellular stress responses and senescence signaling in vascular and renal tissues of ...
Hongli Zhang,Jihong Ren,Yan He et al. Hongli Zhang et al.
Pulmonary arterial hypertension (PAH) is a progressive cardiovascular disease characterized by elevated pulmonary arterial pressure and vascular remodeling. However, the underlying mechanisms remain unclear. This study reveals a novel mecha...
Mauro Trincado Ave,María Brión,Alejandro Blanco-Verea et al. Mauro Trincado Ave et al.
A 25% flecainide dose reduction has been recommended for intermediate metabolisers (IMs); however, studies have yielded contradictory results, likely due to the lack of standardisation in CYP2D6 pharmacogenetic classifications. We aimed to ...
Michele Marchetta,Michele Golino,John D Markley et al. Michele Marchetta et al.
The extensive use of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines has played a crucial role in controlling the Coronavirus disease 2019 (COVID-19) pandemic, underscoring the remarkable advantages and efficacy of nov...
Giuseppe Biondi-Zoccai,Attilio Lauretti,Stefan Agewall et al. Giuseppe Biondi-Zoccai et al.
Artificial intelligence (AI) has been increasingly integrated into medical publishing, hopefully improving efficiency and accuracy, but serious concerns persist regarding ethical implications, authorship attribution, and content reliability...
Giuseppe Biondi-Zoccai,Vassilios S Vassiliou,Maria Camilla Palumbo et al. Giuseppe Biondi-Zoccai et al.
Phthalates, widely used as plasticizers in industrial and medical products, are increasingly recognized as cardiovascular health disruptors. Their ubiquity poses a significant threat, particularly to patients with or at risk of cardiovascul...